Showing 151-160 of 345 grants

Title Institution Researcher Program Duration Total Award Amount
Expanding Access to T1D Care through the PEN-Plus Strategy The Brigham and Women’s Hospital, Inc. Gene Bukhman Mission 01-August-2024 to 31-July-2027 $5,999,961.29
A prodrug system for targeted activation of small molecules in beta cells The Brigham and Women’s Hospital, Inc. Amit Choudhary Cures 01-February-2024 to 31-January-2027 $2,250,000.00
Targeting Prostaglandin F-series Lipids to Counter Beta-Cell-Death and T1D Development The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham Sasanka Ramanadham Cures 01-May-2023 to 30-April-2026 $749,763.00
Immune-cell targeted TLR7 antagonist to halt the attack on beta−cells in the context of Type 1 Diabetes Tezcat Bio Craig Ramirez Cures 15-January-2026 to 31-December-2026 $100,000.00
Implementing Best Practice Advisories to Reduce Inequities in Technology Use for people with Type 1 Diabetes T1D Exchange, Inc. Nicole Rioles Improving Lives 01-May-2024 to 30-April-2027 $1,995,534.06
Research and Data Research T1D Exchange, Inc. Jaime Lucove Transportfolio 01-December-2022 to 30-November-2025 $620,435.07
Programming Pancreatic Cell Replacement Therapeutics Using Cellgorithm Technology Syntax Bio, Inc Ryan Clarke Cures 15-November-2025 to 14-November-2027 $856,250.00
Novel insulin formulations for pumps Stanford University Yanxian Zhang Improving Lives 01-March-2023 to 28-February-2026 $243,986.00
Single-arm intervention trial of TWIIST™ AID DEKA Loop insulin pump in pregnant women with pre-existing type 1 diabetes Stanford University Tugce Akcan Improving Lives 01-March-2025 to 28-February-2027 $180,600.00
Optimized bone marrow conditioning and tolerance assays to advance cell-based therapies for diabetes Stanford University Stephan Ramos Cures 01-March-2026 to 28-February-2029 $285,000.00